Skip to main content

OncoPep, INC

North Andover, MA
United States

TAP Partner

OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep’s lead program is an investigational, multi-peptide therapeutic vaccine being evaluated in treating smoldering multiple myeloma.

Program Name(s)
Therapy Acceleration Program